nsc 65346 has been researched along with Colonic Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glazer, RI; Hartman, KD | 2 |
| Cohen, MB; Glazer, RI | 2 |
4 other study(ies) available for nsc 65346 and Colonic Neoplasms
| Article | Year |
|---|---|
In vitro translational activity of messenger RNA following treatment of human colon carcinoma cells with sangivamycin.
Topics: Antibiotics, Antineoplastic; Cell-Free System; Cells, Cultured; Colonic Neoplasms; Humans; Protein Biosynthesis; Pyrimidine Nucleosides; Reticulocytes; RNA, Messenger; RNA, Neoplasm | 1983 |
Cytokinetic and biochemical effects of sangivamycin in human colon carcinoma cells in culture.
Topics: Antibiotics, Antineoplastic; Cell Division; Cells, Cultured; Colonic Neoplasms; DNA, Neoplasm; Humans; Neoplasms, Experimental; Pyrimidine Nucleosides; RNA, Neoplasm; Time Factors | 1981 |
Cytotoxicity and the inhibition of ribosomal RNA processing in human colon carcinoma cells.
Topics: Azacitidine; Azaguanine; Cell Survival; Cells, Cultured; Colonic Neoplasms; Fluorouracil; Humans; Protein Biosynthesis; Pyrimidine Nucleosides; RNA, Ribosomal; Toyocamycin; Tubercidin | 1985 |
Comparison of the cellular and RNA-dependent effects of sangivamycin and toyocamycin in human colon carcinoma cells.
Topics: Antibiotics, Antineoplastic; Cell Survival; Colonic Neoplasms; Humans; In Vitro Techniques; Leucine; Methylation; Protein Biosynthesis; Pyrimidine Nucleosides; Ribonucleosides; RNA; RNA, Ribosomal; Time Factors; Toyocamycin; Uridine | 1985 |